PREVIOUS QUESTION:

 

NEXT QUESTION:

 

What is a syngeneic transplant?

ANSWER

Syngeneic transplants are allogeneic transplants that come from an identical twin. If you’re lucky enough to have one, this may be your best option because the transplanted cells will be the best match they can be.

SOURCES:

National Heart, Lung, and Blood Institute: “What Is a Blood and Marrow Stem Cell Transplant?”

American Cancer Society: “Stem Cell Transplant for Multiple Myeloma,” “What’s It Like to Get a Stem Cell Transplant?” “What Are Stem Cells and Why Are They Transplanted?” “The Transplant Process.”

OncoLink - Abramson Cancer Center of the University of Pennsylvania: “Autologous Stem Cell Transplant or Bone Marrow Transplant.”

International Myeloma Foundation: “Understanding High-Dose Therapy with Stem Cell Rescue.”

Up-to-Date:  “Patient Information: Multiple Myeloma Treatment (Beyond the Basics),” “Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics).”

Giralt, S. , May 2014. Clinical Advances in Hematology & Oncology

Cancer Medicine : “Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained response.”

Reviewed by Laura J. Martin on October 08, 2018

WAS THIS ANSWER HELPFUL

SOURCES:

National Heart, Lung, and Blood Institute: “What Is a Blood and Marrow Stem Cell Transplant?”

American Cancer Society: “Stem Cell Transplant for Multiple Myeloma,” “What’s It Like to Get a Stem Cell Transplant?” “What Are Stem Cells and Why Are They Transplanted?” “The Transplant Process.”

OncoLink - Abramson Cancer Center of the University of Pennsylvania: “Autologous Stem Cell Transplant or Bone Marrow Transplant.”

International Myeloma Foundation: “Understanding High-Dose Therapy with Stem Cell Rescue.”

Up-to-Date:  “Patient Information: Multiple Myeloma Treatment (Beyond the Basics),” “Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics).”

Giralt, S. , May 2014. Clinical Advances in Hematology & Oncology

Cancer Medicine : “Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained response.”

Reviewed by Laura J. Martin on October 08, 2018

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.